Mesenchymal Stem Cells Modulate Regulatory T Cells: From Molecular Mechanisms to Disease Therapy
Stem Cells International · 2026-01 · 2026 (1)
DOI: 10.1155/sci/6457805 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cells International, online erschienen am 09.08.2026. Verfasst von Meng Yuan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, Jiangsu, China, ujs.edu.cn. Die Arbeit nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mesenchymal stem cells (MSCs) and regulatory T cells (Tregs) form a key immunoregulatory axis essential for maintaining immune homeostasis and treating autoimmune diseases, transplant rejection, and inflammatory disorders. Although both MSCs and Tregs have been individually studied, a clear synthesis of how MSCs regulate Treg function across distinct mechanistic layers and disease contexts remains lacking. MSCs regulate Treg differentiation, expansion, and functional stability through paracrine signaling, intercellular contact–dependent pathways, extracellular vesicle (EV)–mediated transfer of microRNAs (miRNAs) and proteins, mitochondrial transfer, and metabolic and epigenetic reprogramming. These mechanisms restore Th17/Treg balance, suppress inflammation, and promote tissue repair. Preclinical studies demonstrate strong therapeutic potential in multiple immune–mediated diseases; however, clinical translation remains limited. Unlike previous studies, this review integrates soluble and exosomal signaling pathways, compares shared and disease‐specific regulatory mechanisms, and critically evaluates MSC source variability, methodological limitations, and causes of clinical inconsistency. It aims to provide a conceptual framework to guide future mechanistic studies and clinical development of MSC–Treg–based therapies.
Autor:innen und Institutionen
- Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, Jiangsu, China, ujs.edu.cn.
- Department of Laboratory Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang 212002, Jiangsu, China, ujs.edu.cn.
- The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Zhenjiang 212300, Jiangsu, China.
- Danyang Maternal and Child Health Hospital, Zhenjiang 212300, Jiangsu, China.
ORCID-Profile: Meng Yuan, Ting Sun, Yaru Qiao, Peter Muro, Bo Wang, Xiangjun Zhou, Fei Mao
Zitieren
APA
Yuan, M., Sun, T., Qiao, Y., Muro, P., Wang, B., Zhou, X., & Mao, F. (2026). Mesenchymal Stem Cells Modulate Regulatory T Cells: From Molecular Mechanisms to Disease Therapy. Stem Cells International, 2026(1). https://doi.org/10.1155/sci/6457805
Vancouver
Yuan M, Sun T, Qiao Y, Muro P, Wang B, Zhou X, et al. Mesenchymal Stem Cells Modulate Regulatory T Cells: From Molecular Mechanisms to Disease Therapy. Stem Cells International. 2026;2026(1). doi:10.1155/sci/6457805
BibTeX
@article{Yuan2026,
author = {Yuan, Meng and Sun, Ting and Qiao, Yaru and Muro, Peter and Wang, Bo and Zhou, Xiangjun and Mao, Fei},
title = {Mesenchymal Stem Cells Modulate Regulatory T Cells: From Molecular Mechanisms to Disease Therapy},
journal = {Stem Cells International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/sci/6457805}
}
EUVIMED